These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26380651)

  • 1. Markers of bacterial translocation in end-stage liver disease.
    Koutsounas I; Kaltsa G; Siakavellas SI; Bamias G
    World J Hepatol; 2015 Sep; 7(20):2264-73. PubMed ID: 26380651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial translocation markers in liver cirrhosis.
    Alexopoulou A; Agiasotelli D; Vasilieva LE; Dourakis SP
    Ann Gastroenterol; 2017; 30(5):486-497. PubMed ID: 28845103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.
    Bellot P; Francés R; Such J
    Liver Int; 2013 Jan; 33(1):31-9. PubMed ID: 23121656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.
    Tsiaoussis GI; Assimakopoulos SF; Tsamandas AC; Triantos CK; Thomopoulos KC
    World J Hepatol; 2015 Aug; 7(17):2058-68. PubMed ID: 26301048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis.
    Riva A; Gray EH; Azarian S; Zamalloa A; McPhail MJW; Vincent RP; Williams R; Chokshi S; Patel VC; Edwards LA
    JHEP Rep; 2020 Dec; 2(6):100151. PubMed ID: 32838247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial translocation and its consequences in patients with cirrhosis.
    Guarner C; Soriano G
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):27-31. PubMed ID: 15647636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis.
    Ilan Y
    World J Gastroenterol; 2012 Jun; 18(21):2609-18. PubMed ID: 22690069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction mechanism of shock: applying the etiology in judgment of the cause of death in forensic practice].
    Tanaka N
    Nihon Hoigaku Zasshi; 2004 Sep; 58(2):130-40. PubMed ID: 15526767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of translocation.
    Van Leeuwen PA; Boermeester MA; Houdijk AP; Ferwerda CC; Cuesta MA; Meyer S; Wesdorp RI
    Gut; 1994 Jan; 35(1 Suppl):S28-34. PubMed ID: 8125386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of NOD2 risk variants on hepatic encephalopathy and association with inflammation, bacterial translocation and immune activation.
    Ripoll C; Greinert R; Reuken P; Reichert MC; Weber SN; Hupfer Y; Staltner R; Meier Clinien M; Lammert F; Bruns T; Zipprich A
    Liver Int; 2023 Aug; 43(8):1793-1802. PubMed ID: 37249050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis.
    Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F
    Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of immunity and bacterial translocation in cirrhosis.
    Mortensen C
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacterial translocation in cirrhosis].
    Bellot P; Francés R; Such J
    Gastroenterol Hepatol; 2008 Oct; 31(8):508-14. PubMed ID: 18928751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-related complications in cirrhosis.
    Gómez-Hurtado I; Such J; Sanz Y; Francés R
    World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial translocation (BT) in cirrhosis.
    Wiest R; Garcia-Tsao G
    Hepatology; 2005 Mar; 41(3):422-33. PubMed ID: 15723320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis.
    Zhang SC; Wang W; Ren WY; He BM; Zhou K; Zhu WN
    World J Gastroenterol; 2003 Mar; 9(3):534-8. PubMed ID: 12632513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal permeability in a patient with liver cirrhosis.
    Aguirre Valadez JM; Rivera-Espinosa L; Méndez-Guerrero O; Chávez-Pacheco JL; García Juárez I; Torre A
    Ther Clin Risk Manag; 2016; 12():1729-1748. PubMed ID: 27920543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl
    Xu H; Xiong J; Xu J; Li S; Zhou Y; Chen D; Cai X; Ping J; Deng M; Chen J
    Dig Dis Sci; 2017 Oct; 62(10):2801-2811. PubMed ID: 28815345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial.
    Kimer N; Pedersen JS; Tavenier J; Christensen JE; Busk TM; Hobolth L; Krag A; Al-Soud WA; Mortensen MS; Sørensen SJ; Møller S; Bendtsen F;
    J Gastroenterol Hepatol; 2018 Jan; 33(1):307-314. PubMed ID: 28671712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.